PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
12-Jul-2021 Rheos Medicines Appoints Industry Leader, John Davis, Jr., M.D., M.P.H., M.S., to Board of Directors Businesswire
12-Jul-2021 KalVista Pharmaceuticals Presents Data Showing Single On-Demand Treatment with Orally Administered KVD900 Significantly Slows Progression and Accelerates Resolution of Attacks in Patients with HAE Businesswire
12-Jul-2021 Global Cell and Gene Therapy Market Report 2021: Opportunities, Strategies, COVID-19 Impacts, Growth and Changes to 2030 - ResearchAndMarkets.com Businesswire
12-Jul-2021 Merck Announces Presentation of New Data from Broad HIV Program at IAS 2021 Businesswire
12-Jul-2021 Interim Results from Phase 2/3 Studies of Molnupiravir, an Investigational Oral Antiviral Therapeutic for Mild to Moderate COVID-19, Presented at the European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) Businesswire
12-Jul-2021 MENAGEN-MiddleEast announces commercializing agreement with CKD for Biosimilar Darbepotein Alfa Businesswire
12-Jul-2021 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
12-Jul-2021 Lionheart Acquisition Corp. II Announces Business Combination With MSP Recovery, a Leader in Data-Driven Solutions, Recovering Improperly Paid Benefits on Behalf of Medicare, Medicaid and Commercial Payers Businesswire
12-Jul-2021 Alzamend Neuro, Inc. to Ring Nasdaq Opening Bell Today Businesswire
12-Jul-2021 Outlook on the Irritable Bowel Syndrome Treatment Global Market to 2028 - by Type, Product, Distribution Channel and Geography - ResearchAndMarkets.com Businesswire
12-Jul-2021 Worldwide Artwork Management Software Industry to 2028 - Adoption of Cloud-based Artwork Management Platforms Presents Opportunities - ResearchAndMarkets.com Businesswire
12-Jul-2021 Global Minoxidil Market Report 2021: Product Pipeline Future, Potential Treatments, Strategies and Developments 2020-2025 - ResearchAndMarkets.com Businesswire
12-Jul-2021 Inotrem Receives Approval to Expand Nangibotide Clinical Trial in Critically Ill COVID-19 Patients and Receives Additional Public Funding of €45 Million Businesswire
12-Jul-2021 Poxel Announces New Strategic Direction with Increasing Focus on Rare Metabolic Diseases Following Recent Achievements Businesswire
12-Jul-2021 Deenova Expands its Italy Winning Streak with 9 Year Tender at ASST Vimercate Hospitals Businesswire
12-Jul-2021 AMRI Becomes Curia Businesswire
10-Jul-2021 Glancy Prongay & Murray LLP, a National Class Action Law Firm, Continues Investigation of Full Truck Alliance Co. Ltd. (YMM) on Behalf of Investors Businesswire
10-Jul-2021 Glancy Prongay & Murray LLP, a National Class Action Law Firm, Continues Investigation of Kanzhun Limited (BZ) on Behalf of Investors Businesswire
10-Jul-2021 New Data from the Phase 3 HELP Study™ Open-Label Extension Evaluating Safety and Efficacy of TAKHZYRO® (lanadelumab) for Hereditary Angioedema Patients to be Presented at European Academy of Allergy and Clinical Immunology (EAACI) Hybrid Congress Businesswire
09-Jul-2021 PharmaCyte Biotech Announces Reverse Stock Split Businesswire